Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States

BACKGROUND: The total population health benefits and costs of HIV preexposure prophylaxis (PrEP) for people who inject drugs (PWID) in the United States are unclear. OBJECTIVE: To evaluate the cost-effectiveness and optimal delivery conditions of PrEP for PWID. DESIGN: Empirically calibrated dynamic...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Intern Med
Main Authors: Bernard, Cora L., Brandeau, Margaret L., Humphreys, Keith, Bendavid, Eran, Holodniy, Mark, Weyant, Christopher, Owens, Douglas K., Goldhaber-Fiebert, Jeremy D.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118181/
https://ncbi.nlm.nih.gov/pubmed/27110953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M15-2634
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki